Our Science
SNAP Biosciences is developing a novel chimeric antigen receptor (CAR)-based cell therapy called SNAP-CAR that overcomes several limitations of traditional CAR technology.
At its core, SNAP-CAR utilizes a “universal” CAR system that combines the dynamic and cost-effective advantages of antibodies with the therapeutic power and “off-the-shelf” compatibility of NK cells.
There are three major components to SNAP-CAR
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.